• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

适应性平台试验中非同期对照的分析:区分随机化与非随机化信息。

Analysis of Nonconcurrent Controls in Adaptive Platform Trials: Separating Randomized and Nonrandomized Information.

机构信息

NHMRC Clinical Trials Centre, University of Sydney, Sydney, NSW, Australia.

出版信息

Biom J. 2024 Sep;66(6):e202300334. doi: 10.1002/bimj.202300334.

DOI:10.1002/bimj.202300334
PMID:39104093
Abstract

Adaptive platform trials allow treatments to be added or dropped during the study, meaning that the control arm may be active for longer than the experimental arms. This leads to nonconcurrent controls, which provide nonrandomized information that may increase efficiency but may introduce bias from temporal confounding and other factors. Various methods have been proposed to control confounding from nonconcurrent controls, based on adjusting for time period. We demonstrate that time adjustment is insufficient to prevent bias in some circumstances where nonconcurrent controls are present in adaptive platform trials, and we propose a more general analytical framework that accounts for nonconcurrent controls in such circumstances. We begin by defining nonconcurrent controls using the concept of a concurrently randomized cohort, which is a subgroup of participants all subject to the same randomized design. We then use cohort adjustment rather than time adjustment. Due to flexibilities in platform trials, more than one randomized design may be in force at any time, meaning that cohort-adjusted and time-adjusted analyses may be quite different. Using simulation studies, we demonstrate that time-adjusted analyses may be biased while cohort-adjusted analyses remove this bias. We also demonstrate that the cohort-adjusted analysis may be interpreted as a synthesis of randomized and indirect comparisons analogous to mixed treatment comparisons in network meta-analysis. This allows the use of network meta-analysis methodology to separate the randomized and nonrandomized components and to assess their consistency. Whenever nonconcurrent controls are used in platform trials, the separate randomized and indirect contributions to the treatment effect should be presented.

摘要

适应性平台试验允许在研究过程中添加或删除治疗方法,这意味着对照组可能比实验组活跃更长时间。这导致了非同期对照,提供了非随机信息,可能提高效率,但可能会因时间混杂和其他因素引入偏倚。已经提出了各种基于时间段调整的方法来控制非同期对照的混杂。我们证明,在某些情况下,时间调整不足以防止适应性平台试验中存在非同期对照时的偏倚,并且我们提出了一种更通用的分析框架,用于在这种情况下考虑非同期对照。我们首先使用同时随机化队列的概念来定义非同期对照,同时随机化队列是所有参与者都受到相同随机设计影响的一个亚组。然后,我们使用队列调整而不是时间调整。由于平台试验的灵活性,在任何时候可能有不止一种随机设计生效,这意味着队列调整和时间调整分析可能有很大的不同。通过模拟研究,我们证明时间调整分析可能存在偏倚,而队列调整分析可以消除这种偏倚。我们还证明,队列调整分析可以被解释为类似于混合治疗比较的网络荟萃分析中的随机和间接比较的综合。这允许使用网络荟萃分析方法来分离随机和非随机成分,并评估它们的一致性。只要在平台试验中使用非同期对照,就应该呈现治疗效果的单独随机和间接贡献。

相似文献

1
Analysis of Nonconcurrent Controls in Adaptive Platform Trials: Separating Randomized and Nonrandomized Information.适应性平台试验中非同期对照的分析:区分随机化与非随机化信息。
Biom J. 2024 Sep;66(6):e202300334. doi: 10.1002/bimj.202300334.
2
Analysis of adaptive platform trials using a network approach.网络分析法在适应性平台试验中的应用分析。
Clin Trials. 2022 Oct;19(5):479-489. doi: 10.1177/17407745221112001. Epub 2022 Aug 22.
3
Examining the bias-efficiency tradeoff from incorporation of nonconcurrent controls in platform trials: A simulation study example from the adaptive COVID-19 treatment trial.考察平台试验中纳入非同期对照所带来的偏倚-效率权衡:来自适应性COVID-19治疗试验的模拟研究示例
Clin Trials. 2025 Feb 8:17407745251313928. doi: 10.1177/17407745251313928.
4
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
5
Characteristics, Progression, and Output of Randomized Platform Trials: A Systematic Review.随机平台试验的特征、进展和结果:系统评价。
JAMA Netw Open. 2024 Mar 4;7(3):e243109. doi: 10.1001/jamanetworkopen.2024.3109.
6
On model-based time trend adjustments in platform trials with non-concurrent controls.基于模型的平台试验中非同期对照的时间趋势调整。
BMC Med Res Methodol. 2022 Aug 15;22(1):228. doi: 10.1186/s12874-022-01683-w.
7
On the use of non-concurrent controls in platform trials: a scoping review.在平台试验中使用非同期对照:范围综述。
Trials. 2023 Jun 15;24(1):408. doi: 10.1186/s13063-023-07398-7.
8
The future of Cochrane Neonatal.考克兰新生儿协作网的未来。
Early Hum Dev. 2020 Nov;150:105191. doi: 10.1016/j.earlhumdev.2020.105191. Epub 2020 Sep 12.
9
The Bayesian Time Machine: Accounting for temporal drift in multi-arm platform trials.贝叶斯时间机器:多臂平台试验中时间漂移的考量
Clin Trials. 2022 Oct;19(5):490-501. doi: 10.1177/17407745221112013. Epub 2022 Aug 22.
10
Overview of the epidemiology methods and applications: strengths and limitations of observational study designs.流行病学方法与应用概述:观察性研究设计的优势与局限性。
Crit Rev Food Sci Nutr. 2010;50 Suppl 1(s1):10-2. doi: 10.1080/10408398.2010.526838.

引用本文的文献

1
Design Considerations for a Phase II Platform Trial in Major Depressive Disorder.重度抑郁症II期平台试验的设计考量
Pharm Stat. 2025 Sep-Oct;24(5):e70025. doi: 10.1002/pst.70025.
2
Statistical Modeling to Adjust for Time Trends in Adaptive Platform Trials Utilizing Non-Concurrent Controls.利用非同期对照对适应性平台试验中的时间趋势进行调整的统计建模。
Biom J. 2025 Jun;67(3):e70059. doi: 10.1002/bimj.70059.